Bio Techne (TECH) Return on Equity ROE from the fourth quarter 2026 to fourth quarter 2025 and annually, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Bio techne Corp  (NASDAQ: TECH)

Bio Techne's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Bio Techne in the fourth quarter 2026?
Bio techne Corp achieved a return on average equity (ROE) of 9.01 % in its fourth quarter 2026, which is below Bio Techne's average return on equity, which stands at 12.69%.

ROE has advanced compared to 5.56% in the third quarter 2026, due to net income growth.

Within the Biotechnology & Pharmaceuticals industry 12 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 1893, from total ROE ranking in the third quarter 2026 at 1896.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2026)
IV. Quarter		 (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter		 (Jun 30 2025)
IV. Quarter
Y / Y Equity Change 9.87 % 3.33 % -7.25 % -8.08 % -
Y / Y Net Income Change - 125.99 % 8.94 % 13.65 % -
Net Income (TTM) in Millions 182 110 81 78 73
Return On Equity (TTM) 9.01 % 5.56 % 4.15 % 3.91 % 3.6 %
TECH's Total Ranking # 1893 # 1896 # 1522 # 1790 # 1803
Equity (TTM) in Millions 2,108 2,085 1,919 1,966 1,919
Seq. Equity Change 1.1 % 8.68 % -2.39 % 2.45 % -4.92 %
Seq. Net Income Change 7 % 34.3 % -0.46 % - -

Back to TECH Management Effectiveness >> TECH's 5 Years Annual ROE >> Compare TECH ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 13
Sector # 151
Overall # 1893

Return On Equity Statistics
High Average Low
19.98 %
12.69 %
3.6 %
(Dec 31 2011)   (Jun 30 2025)





TECH Annual Return On Equity (Jun 30 2026)
2026		 (Jun 30 2025)
2025		 (Jun 30 2024)
2024		 (Jun 30 2023)
2023		 (Jun 30 2022)
2022
Total Equity in Millions 2,108 1,919 2,069 1,967 1,701
Y / Y Equity Change 9.87 % -7.25 % 5.2 % 15.61 % 8.26 %
Net Income in Millions 182 73 168 285 263
Y / Y Net Income Change 147.77 % -56.34 % -41.11 % 8.49 % 88.49 %
Return On Equity 8.63 % 3.83 % 8.13 % 14.52 % 15.47 %

Back to TECH Management Effectiveness >> TECH's 5 Years Annual ROE >> Compare TECH ROE to its Competitors




Annual Roe Comment
In 2026 ROE improved to 8.63 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
TECH's' Return on Equity at Yahoo Finance
TECH's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for TECH's Competitors
Subscribers only: Roe for Bio Techne's Suppliers
Subscribers only: Return On Equity for TECH's Customers




Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector ROE
Resmed Inc   24.21 %
Healthcare Services Group Inc   24.12 %
Electromed Inc   23.65 %
Iradimed Corporation  23.45 %
Vertex Pharmaceuticals Inc  23.31 %
Lantheus Holdings Inc   23.27 %
Msa Safety Inc  23.15 %
Prestige Consumer Healthcare Inc   21.77 %
Jazz Pharmaceuticals Plc  21.37 %
Neurocrine Biosciences Inc   21.13 %
Universal Health Services Inc   20.89 %
Puma Biotechnology Inc   20.85 %
Entera Bio Ltd   20.82 %
United Therapeutics Corporation  20.18 %
Ligand Pharmaceuticals Incorporated  20.06 %
Harmony Biosciences Holdings inc   20.06 %
Pediatrix Medical Group Inc   19.89 %
Theravance Biopharma inc   19.40 %
Krystal Biotech Inc   19.34 %
Ani Pharmaceuticals Inc  19.33 %
Brightspring Health Services Inc   18.93 %
Sbc Medical Group Holdings Incorporated  18.69 %
West Pharmaceutical Services Inc   18.51 %
Intuitive Surgical Inc   17.82 %
Standard Biotools Inc   17.64 %
Inspire Medical Systems inc   17.62 %
Medinotec Inc   17.47 %
Lemaitre Vascular Inc   16.93 %
Ufp Technologies Inc   16.72 %
Ensign Group Inc  16.53 %

Date modified: 2026-08-29T04:46:53+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.